Liposaccharide natural compounds consisting of a trisaccharide repeating unit (two heptose units and octulosonic acid) with oligosaccharide side chains and 3-hydroxytetradecanoic acid units (they are a major constituent of the cell walls of Gram-negative bacteria).
Chemical ID:
MESH:D008070
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [ACE2 protein inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]]; 7-Ala-angiotensin (1-7) inhibits the reaction [ACE2 protein inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]]; [[Simvastatin co-treated with Lipopolysaccharides] results in increased expression of HMOX1 protein] which results in increased phosphorylation of NFKBIA protein; [Lipopolysaccharides co-treated with IFNG protein] results in increased degradation of NFKBIA protein; [Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in decreased expression of NFKBIA protein; ACE2 protein inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in decreased expression of NFKBIA protein]; broussochalcone A inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Buthionine Sulfoximine inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Buthionine Sulfoximine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Carmustine inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Carmustine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; CD40 protein affects the reaction [Curcumin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; CD40 protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Curcumin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Curcumin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Cysteine analog inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; ICAM1 protein affects the reaction [Curcumin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; ICAM1 protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Lipopolysaccharides results in increased phosphorylation of and results in decreased expression of NFKBIA protein; Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein; manganese chloride promotes the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased degradation of NFKBIA protein]; MAP3K14 protein affects the reaction [Manganese promotes the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; MIR16 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; OGT inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Reactive Oxygen Species affects the reaction [manganese chloride promotes the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; Resveratrol analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; RV09 compound inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; wuzi yanzong analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]
Lipopolysaccharides results in increased expression of NFKBIA mRNA; Lipopolysaccharides results in increased expression of NFKBIA protein; Lipopolysaccharides results in increased expression of NFKBIA protein modified form
1-bromopropane inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; 1-dodecylsulfonyl-5N,6O-oxomethylidenenojirimycin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; 17-hydroxyjolkinolide B inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; 3-methylcatechol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; 3-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; 4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; 4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; 6alpha-ethyl-23(S)-methylcholic acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 2,4,5,2',5'-pentachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; [[Simvastatin co-treated with Lipopolysaccharides] results in increased expression of HMOX1 protein] which results in increased phosphorylation of NFKBIA protein; [Cisplatin promotes the reaction [Lipopolysaccharides binds to TLR4 protein]] which results in increased phosphorylation of NFKBIA protein; [Drugs, Chinese Herbal co-treated with niuhuang] inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; [Drugs, Chinese Herbal co-treated with Selenium] inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; [Ethanol co-treated with Lipopolysaccharides] results in increased expression of NFKBIA protein modified form; [Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of NFKBIA protein; [Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of and results in increased degradation of NFKBIA protein; [Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of NFKBIA protein; [Lipopolysaccharides co-treated with TLR4] results in increased phosphorylation of NFKBIA protein; [Lipopolysaccharides co-treated with trovafloxacin] results in increased expression of NFKBIA mRNA; [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; aciculatin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; alachlor inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; allylpyrocatechol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; alternaramide inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; apigenin-6,8-di-C-glycopyranoside inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]; arctigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; arctiin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; aristolochic acid I inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of NFKBIA protein]; aristolochic acid I inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; asarone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; astragalin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Auranofin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; aureusidin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of NFKBIA protein]; Bee Venoms inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Bee Venoms inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Berberine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Bile Acids and Salts analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; bis(3-hydroxyphenyl) diselenide inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Carticaine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; CAT protein inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; catechol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; cavidine inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; citronellol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; coagulin-L inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; cordycepin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; cordycepin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]; daidzein inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; dehydrodiisoeugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; diallyl disulfide inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of NFKBIA protein modified form]; dimemorfan inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; dimethylacetamide inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; diosmetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Eicosapentaenoic Acid promotes the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]; EIF2AK2 protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of NFKBIA protein]; epimuqubilin A inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; eriodictyol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; erythraline inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; ethyl N-allyl-N-(2-methyl-3-(4-(4-amidinophenoxycarbonyl)phenyl)propenoyl)aminoacetate methanesulfonate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; ferulic acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; flavokawain A inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Fluoxetine inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; formic acid inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Fulvestrant inhibits the reaction [notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]]; geraniol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA protein modified form]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; glyceryl-isoeugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; glycyrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; GW 506033X inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; helenalin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; homoeriodictyol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; icariin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; IL10 protein inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Indirubin E804 inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]; isoeugenol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Isothiocyanates inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; kaempferol 7-O-glucoside inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; kaempferol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Lipopolysaccharides affects the localization of and affects the activity of NFKBIA protein; Lipopolysaccharides inhibits the reaction [Indirubin E804 results in decreased expression of NFKBIA mRNA]; Lipopolysaccharides results in decreased expression of and results in increased phosphorylation of NFKBIA protein; Lipopolysaccharides results in increased degradation of and results in increased phosphorylation of NFKBIA protein; Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein; lipoxin A4 inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Luteolin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; luteolin-7-O-glucuronide inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; macrosphelide B inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; MAPKAPK2 protein affects the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Melitten inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Melitten inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; MK615 extract inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; monotropein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; narciclasine inhibits the reaction [Lipopolysaccharides results in increased degradation of and results in increased phosphorylation of NFKBIA protein]; naringenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]; patchouli alcohol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]; Plant Extracts inhibits the reaction [Lipopolysaccharides affects the localization of NFKBIA protein]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Plant Oils inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Plant Oils promotes the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; praeruptorin A inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; prosapogenin D methyl ester inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; pyrazole analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Quercetin analog inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Quercetin inhibits the reaction [Lipopolysaccharides results in decreased expression of and results in increased phosphorylation of NFKBIA protein]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Raloxifene Hydrochloride inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with TLR4] results in increased phosphorylation of NFKBIA protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; salvin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; sanggenon O inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; sanggenone C inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; scolymoside inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]; scutellarein tetramethyl ether inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; SFRP5 protein affects the reaction [Raloxifene Hydrochloride inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Silymarin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of NFKBIA protein]; Simvastatin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; sinapinic acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Sirolimus inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; sodium arsenite inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; sodium arsenite promotes the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]; sophocarpine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; sophoricoside inhibits the reaction [Lipopolysaccharides results in decreased expression of and results in increased phosphorylation of NFKBIA protein]; soyasaponin Ab inhibits the reaction [Lipopolysaccharides results in increased degradation of and results in increased phosphorylation of NFKBIA protein]; soyasaponin I inhibits the reaction [Lipopolysaccharides results in increased degradation of and results in increased phosphorylation of NFKBIA protein]; Sterols inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Sulfasalazine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; tanshinone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; timosaponin B-II inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; TLR4 protein promotes the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; TNFAIP3 protein affects the reaction [Lipopolysaccharides results in increased degradation of and results in increased phosphorylation of NFKBIA protein]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; trilobatin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; vitisin A inhibits the reaction [Lipopolysaccharides results in increased degradation of and results in increased phosphorylation of NFKBIA protein]; Wortmannin inhibits the reaction [notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]]; zinc protoporphyrin inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]]
1-bromopropane inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; 3-hydro-2,2,5,6-tetramethylpyrazine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; [Adenosine Triphosphate co-treated with Lipopolysaccharides] affects the localization of NFKBIA protein; [IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NFKBIA protein modified form; [IFNG protein co-treated with Lipopolysaccharides] results in increased phosphorylation of NFKBIA protein; [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in decreased expression of NFKBIA mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NFKBIA mRNA; [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of NFKBIA mRNA; [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NFKBIA mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of NFKBIA mRNA; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Nicotine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; Amifostine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Aspirin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; atractylodin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Bee Venoms inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; CBR1 protein modified form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Eucalyptol inhibits the reaction [Lipopolysaccharides affects the expression of NFKBIA protein]; Eucalyptol inhibits the reaction [Lipopolysaccharides inhibits the reaction [RELA protein binds to NFKBIA protein]]; Fluorocarbons inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; fraxinellone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; gingerenone A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in decreased expression of NFKBIA protein]; glucosamine 6-O-sulfate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; HNRNPD protein promotes the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; HOXA-AS2 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Lipopolysaccharides affects the expression of and results in increased phosphorylation of NFKBIA protein; Lipopolysaccharides inhibits the reaction [7-difluoromethyl-5,4'-dimethoxygenistein results in increased expression of NFKBIA protein]; Lipopolysaccharides inhibits the reaction [RELA protein binds to NFKBIA protein]; Lipopolysaccharides results in increased phosphorylation of and results in decreased expression of NFKBIA protein; Lipopolysaccharides results in increased phosphorylation of and results in increased activity of NFKBIA protein; Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein; MAVS protein affects the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]; Melitten inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; MIR106B mRNA inhibits the reaction [HOXA-AS2 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; monophosphoryl lipid A inhibits the reaction [USP18 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; NFKBIA gene mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of BAG3 protein]; NFKBIA protein inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 protein]; NFKBIA protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; NFKBIA protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1RN protein]; NFKBIA protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; NFKBIA protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; NFKBIA protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF1A protein]; NFKBIA protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF1B protein]; NFKBIA protein inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein]; NFKBIA protein mutant form inhibits the reaction [Lipopolysaccharides promotes the reaction [TGFB1 results in increased expression of PDGFB mRNA]]; Nicotine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; notoginsenoside R1 promotes the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]; NSC 74859 inhibits the reaction [Nicotine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; Particulate Matter analog inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]; PPARG mutant form inhibits the reaction [Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]]; pyrazolanthrone inhibits the reaction [Bee Venoms inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; pyrazolanthrone inhibits the reaction [Melitten inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Resveratrol analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Resveratrol inhibits the reaction [[Adenosine Triphosphate co-treated with Lipopolysaccharides] affects the localization of NFKBIA protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]; RIGI protein affects the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]; Silymarin inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]; Sirolimus inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; surfactin peptide results in decreased susceptibility to [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Telmisartan inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; TLR4 protein promotes the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NFKBIA protein modified form]; USP18 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]; Vehicle Emissions analog inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]
